证券记录 · 已归档季度
MIRM
Mirum Pharmaceuticals, Inc. · Healthcare · Biotechnology
20被追踪持有人
0Δ持有人
17.64M持有股份
$1.29B报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +18.1% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 7.39K | $161,236 | n/a | n/a |
| Q2 2026 | 105 | +1 | 35.65M | $4.17B | +8 | −7 |
| Q1 2026 | 107 | +6 | 39.52M | $3.63B | +12 | −7 |
| Q4 2025 | 102 | +1 | 36.05M | $2.83B | +2 | n/a |
| Q3 2025 | 20 | 0 | 17.64M | $1.29B | n/a | n/a |
| Q2 2025 | 17 | +1 | 13.61M | $692.65M | +2 | −1 |
| Q1 2025 | 13 | +1 | 7.45M | $335.67M | +2 | −1 |
| Q4 2024 | 12 | 0 | 6.63M | $274.04M | +1 | −1 |
| Q3 2024 | 11 | +2 | 4.84M | $188.84M | +2 | n/a |
| Q2 2024 | 9 | n/a | 4.39M | $149.94M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 3.60M | +0.7% | $264.09M | 0.0% | ▲ Add | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (被动) | 2.55M | -0.8% | $186.60M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 1.35M | -2.1% | $98.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.28M | -9.4% | $94.08M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | Citadel Advisors ✦ | 1.04M | -26.0% | $76.28M | 0.1% | ▼ Trim | 6 | SEC ↗ ×3 |
| 6 | Geode Capital Management ✦ (被动) | 1.01M | -1.9% | $74.06M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | D. E. Shaw & Co. ✦ | 923.51K | +66.4% | $67.70M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 790.69K | +566.9% | $57.97M | 0.0% | ▲ Add | 6 | SEC ↗ ×7 |
| 9 | Point72 Asset Management ✦ | 790.67K | +205.4% | $57.96M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 10 | Morgan Stanley ✦ | 670.15K | n/a | $49.13M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 11 | Fidelity (FMR) ✦ | 640.22K | +977.1% | $46.93M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 12 | Arrowstreet Capital ✦ | 612.32K | +709.5% | $44.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 513.45K | +29.5% | $37.64M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 497.47K | +104.7% | $36.47M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 15 | Goldman Sachs Group ✦ | 450.84K | n/a | $33.05M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 16 | Two Sigma Investments ✦ | 343.13K | +99.7% | $25.15M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Millennium Management ✦ | 309.03K | +7.2% | $22.66M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 200.42K | n/a | $14.69M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 19 | Marshall Wace ✦ | 39.83K | +56.0% | $2.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 31.39K | -33.9% | $2.30M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 308 持有人, 67.83M 股份, $6.01B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 14
BJERKHOLT ERIC
Officer · 9.94K 股 · $978,093
Sep 02
Howe Jolanda
Officer · 658 股 · $65,800
Aug 18
Howe Jolanda
Officer · 40.00K 股 · $4.00M
Aug 11
BJERKHOLT ERIC
Officer · 6.00K 股 · $599,510
Aug 10
Peetz Christopher
Officer, Director · 2.30K 股 · $230,322
Aug 10
Peetz Christopher
Officer, Director · 6.02K 股 · $597,187
Aug 10
Peetz Christopher
Officer, Director · 11.68K 股 · $1.15M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A: Janus Henderson Group Ltd.
Aug 06
SC 13G: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据